Drug Type Small molecule drug |
Synonyms MLN 608, MLN608 |
Target |
Action inhibitors, antagonists |
Mechanism FLT3 inhibitors(Tyrosine-protein kinase receptor FLT3 inhibitors), PDGFR antagonists(Platelet-derived growth factor receptor antagonists), c-Kit inhibitors(Stem cell growth factor receptor inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma | Preclinical | United States | - |